Neocitran Antitussif indications
Oral
Cough suppression
Adult: For dry non-productive cough: As 50 mg tab: 2 or 3 tabs 8-12 hrly. As 7.5 mg/5 mL syr: 15 mL 4 times daily.
Child: As 50 mg tab:
Neocitran Antitussif description
Each sustained-release film-coated tablet contains 50 mg of Neocitran Antitussif. Each teaspoonful (5 mL) syrup contains 7.5 mg of Neocitran Antitussif.
Neocitran Antitussif dosage
The maximum duration of treatment without doctor's prescription is one week.
Tablet: Adolescents Over 12 Years of Age: 1 or 2 tablets daily.
Adults: 2 or 3 tablets daily at 8 or 12 hour intervals. To be swallowed whole.
Syrup: Children 3 to 6 Years of Age: One teaspoonful (5 mL) 3 times daily.
Children 6 to 12 Years of Age: Two (2) teaspoonfuls (10 mL) 3 times daily.
Adolescents Over 12 Years of Age: One tablespoonful (15 mL) 3 times daily.
Adults: 15 mL 4 times daily.
Wash and dry the graduated cup after each use and between different users.
Neocitran Antitussif interactions
Sulphinpyrazone, a drug used as an antithrombotic agent and inhibitor of platelet aggregation has a potent side effect as a uricosuric agent. The uricosuric side effect increases the urinary excretion of uric acid effectively blocking hepatic conjugation. Tests show that Sulphinpyrazone’s effect on Neocitran Antitussif is a reduction of liver function to 60% of normal without interfering with protein binding. Taking alpha-lipoic acid or chromium with tolbutamide may require a change in the drugs dosage. Use ephedra with caution when taking tolbutamide; ephedra can raise blood sugar levels.
Neocitran Antitussif side effects
Adverse reactions are listed by system organ class and frequency. Frequencies are defined as: Very common (=1/10); common (=1/100 to <1/10); uncommon (=1/1,000 to <1/100); rare (=1/10,000 to <1/1,000); very rare (<1/10,000), or not known (cannot to be estimated from available data). Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Nervous System Disorders: Rare: Somnolence.
Gastrointestinal Disorders: Rare: Nausea, diarrhea.
Skin and Subcutaneous Tissue Disorders: Rare: Urticaria.
Neocitran Antitussif contraindications
You should not take tolbutamide if you have had an allergic reaction to it. Neocitran Antitussif should not be taken if you are suffering from diabetic ketoacidosis (a life-threatening medical emergency caused by insufficient insulin and marked by excessive thirst, nausea, fatigue, pain below the breastbone, and fruity breath). In addition, Neocitran Antitussif should not be used as the sole therapy in treating type 1 (insulin-dependent) diabetes.
Active ingredient matches for Neocitran Antitussif:
Butamirate in Switzerland.
Butamirate citrate in Switzerland.
List of Neocitran Antitussif substitutes (brand and generic names) | Sort by popularity |
| Unit description / dosage (Manufacturer) | Price, USD |
| NeoCitran Hustenstiller Kindertropfen (Switzerland) | |
| Nontoss (Greece) | |
| Notuss Fort (Turkey) | |
| Novamir (Greece) | |
| Oaxen (Greece) | |
| Omnitus (Russian Federation, Serbia) | |
| Syrup; Oral; Butamirate Citrate 4 mg / 5 ml (Pharmed Limited) | |
| Tablet, Modified Release; Oral; Butamirate Citrate 20 mg (Pharmed Limited) | |
| Tablet, Modified Release; Oral; Butamirate Citrate 50 mg (Pharmed Limited) | |
| OMNITUS Liquid / 10mg - 100mg per 5ml / 50ml units (Pharmed Limited) | $ 0.20 |
| Omnitus Dextromethorphan SYR / 50ml (Pharmed Limited) | $ 0.20 |
| 50ml (Pharmed Limited) | $ 0.20 |
| Omnitus 50 ml Syrup (Pharmed Limited) | $ 0.02 |
| OMNITUS syr 50ml (Pharmed Limited) | $ 0.20 |
| Omnitus forte (Bosnia & Herzegowina) | |
| Panatus (Bosnia & Herzegowina, Croatia (Hrvatska), Lithuania, Slovenia) | |
| Syrup; Oral; Butamirate Citrate 4 mg / 5 ml | |
| Tablet, Film-Coated; Oral; Butamirate Citrate 20 mg | |
| Panatus Forte (Croatia (Hrvatska), Slovenia) | |
| Syrup; Oral; Butamirate Citrate 7.5 mg / 5 ml | |
| Tablet, Film-Coated; Oral; Butamirate Citrate 50 mg | |
| Pandigal (Greece) | |
| Physiocod (Greece) | |
| Phytopharma Husten Sirup mit Butamirat (Switzerland) | |
| Pinex Antitusiv (Romania) | |
| Pintal (Greece, Malta) | |
| PULMISTAT (Turkey) | |
| PULMISTAT 10 MG TABLET 1 strip / 15 tablets each (Lupin Ltd) | $ 1.19 |
| Pulmistat Fort (Turkey) | |
| Quintex Pediatrique | |
| Roctylan (Greece) | |
| Rondover (Greece) | |
| Safarol (Greece) | |
| Safarol Medichrom (Greece) | |
| Sinakof (Bangladesh) | |
| Sinecod (Bahrain, Bangladesh, Belgium, Bulgaria, Croatia (Hrvatska), Czech Republic, Egypt, Georgia, Greece, Hungary, Iraq, Italy, Jordan, Kuwait, Latvia, Lebanon, Luxembourg, Malta, Oman, Peru, Poland, Portugal, Qatar, Romania, Russian Federation, Saudi Arabia, Slovakia, Slovenia, Switzerland, Thailand, Turkey, United Arab Emirates, Yemen) | |
| Drops; Oral; Butamirate Citrate 5 mg / ml (Zyma) | |
| Syrup; Oral; Butamirate Citrate 7.5 mg / 5 ml (Zyma) | |
| Tablet; Oral; Butamirate Citrate 50 mg (Zyma) | |
| Sinecod 0.15%/200ml - 1 Syrup (Zyma) | $ 24.00 |
| Sinecod 7.5 mg/5 mL x 1 Bottle 200 mL (Zyma) | |
| Sinecod 5 mg/1 mL x 1 Bottle 20 mL (Zyma) | |
| Sinecod 50 mg x 10 Tablet (Zyma) | |
| Sinecod 4 mg/5 mL x 60 mL (Zyma) | |
| Sinecod 4 mg/5 mL x 120 mL (Zyma) | |
| Sinecod 50 mg x 1 Box 10 Tablet (Zyma) | |
| Sinecod 0.15% (Belgium, Cyprus, Luxembourg) | |
See 169 substitutes for Neocitran Antitussif | |
Reviews
The results of a survey conducted on ndrugs.com for Neocitran Antitussif are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Neocitran Antitussif. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported useful
No survey data has been collected yetConsumer reported price estimates
No survey data has been collected yetConsumer reported time for results
No survey data has been collected yet6 consumers reported age
| Users | % | ||
|---|---|---|---|
| > 60 | 4 | 66.7% | |
| 46-60 | 2 | 33.3% | |
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
